Your session is about to expire
← Back to Search
Behavioral Intervention
Whole-Food Plant-Based Diet for Prostate Cancer (WFPBD Trial)
N/A
Recruiting
Led By David M Nanus, MD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Histologically or cytologically confirmed adenocarcinoma of the prostate
Receiving androgen deprivation therapy (ADT) with an LHRH/GnRH analogue (agonist/antagonist); or have undergone bilateral orchiectomy. Patients with localized prostate cancer, non-metastatic castrate resistant prostate cancer (CRPC), metastatic hormone sensitive prostate cancer and metastatic CRPC are all eligible.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline; 4, 8, and 26 weeks post-randomization
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing whether home-delivered, whole-food, plant-based meals can help men with prostate cancer on ADT manage their weight better than general nutritional counseling.
Who is the study for?
Men over 45 with prostate cancer on androgen-deprivation therapy for at least 24 weeks, who are not currently vegetarian or vegan, without recent chemo/radiation, and no plans to change exercise habits. They must have a good performance status (able to carry out daily activities), adequate organ function, no nut/legume/gluten allergies, and be willing to follow the study procedures.
What is being tested?
The trial is testing if home-delivered whole-food plant-based meals help control weight better than standard nutritional counseling in overweight men with prostate cancer undergoing hormone therapy.
What are the potential side effects?
Since this trial involves dietary changes rather than medication, side effects may include gastrointestinal adjustments like bloating or changes in bowel movements as the body adapts to a plant-based diet.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
My prostate cancer was confirmed by a lab test.
Select...
I am on hormone therapy for prostate cancer or have had surgery to remove my testicles.
Select...
I have been on hormone therapy for prostate cancer for at least 24 weeks and expect to continue for at least 26 more weeks.
Select...
I have been on anti-androgen therapy for at least 3 months and plan to continue.
Select...
It has been over 3 months since I finished my chemotherapy or radiation.
Select...
I am taking medications for bone health.
Select...
I am 45 years old or older.
Select...
I am fully active or can carry out light work.
Select...
My blood tests show my organs and bone marrow are working well.
Select...
I am willing and able to follow all study procedures.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline; 4, 8, and 26 weeks post-randomization
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline; 4, 8, and 26 weeks post-randomization
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Change in weight from baseline to 4 weeks post-randomization
Secondary study objectives
Change in BMI from baseline to 4, 8, and 26 weeks post-randomization.
Change in FACT-P score as an indicator of quality of life from baseline to 4, 8, and 26
Change in levels of HDL from baseline to 4, 8, and 26 weeks post-randomization
+13 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Whole-food, Plant-based Diet (WFPBD)Experimental Treatment1 Intervention
Home-delivered WFPBD meals will be provided to participants, along with nutritional coaching and education. 12 meals a week will be delivered for the first 4 weeks, followed by 6 meals a week for the next 4 weeks. Finally, for the last 18 weeks they will not receive pre-packed meals, but will continue to receive WFPBD coaching. 30 participants are anticipated to be accrued in this arm.
Group II: General Nutrition CounselingActive Control1 Intervention
Participants will receive general nutritional counseling weekly for the first 4 weeks, followed by monthly nutritional counseling for the following 18 weeks. 30 participants are anticipated to be accrued in this arm.
Find a Location
Who is running the clinical trial?
Weill Medical College of Cornell UniversityLead Sponsor
1,085 Previous Clinical Trials
1,147,262 Total Patients Enrolled
49 Trials studying Prostate Cancer
34,597 Patients Enrolled for Prostate Cancer
Plantable Inc.UNKNOWN
Prostate Cancer FoundationOTHER
48 Previous Clinical Trials
2,807 Total Patients Enrolled
27 Trials studying Prostate Cancer
1,900 Patients Enrolled for Prostate Cancer
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am not expected to start any major cancer treatments like radiation or chemotherapy within 2 months of starting the diet plan.I am taking medications for bone health.I am on hormone therapy for prostate cancer or have had surgery to remove my testicles.I am willing and able to follow all study procedures.My blood tests show my organs and bone marrow are working well.I have been on anti-androgen therapy for at least 3 months and plan to continue.I have been on hormone therapy for prostate cancer for at least 24 weeks and expect to continue for at least 26 more weeks.You are currently following a vegetarian or vegan diet.It has been over 3 months since I finished my chemotherapy or radiation.You have allergies to nuts, legumes, or gluten, or you have celiac disease.My prostate cancer was confirmed by a lab test.I am fully active or can carry out light work.You are expected to make changes to your exercise routine during the study.I am 45 years old or older.
Research Study Groups:
This trial has the following groups:- Group 1: Whole-food, Plant-based Diet (WFPBD)
- Group 2: General Nutrition Counseling
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Share this study with friends
Copy Link
Messenger